(Q35771337)

10 August 2017

Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A (English)

1 reference

10 August 2017

1 reference

0 references

P M Elliott

1

1 reference

10 August 2017

H Kindler

2

1 reference

10 August 2017

J S Shah

3

1 reference

10 August 2017

B Sachdev

4

1 reference

10 August 2017

O E Rimoldi

5

1 reference

10 August 2017

R Thaman

6

1 reference

10 August 2017

M T Tome

7

1 reference

10 August 2017

W J McKenna

8

1 reference

10 August 2017

P Lee

9

1 reference

10 August 2017

P G Camici

10

1 reference

10 August 2017

language of work or name

English

0 references

publication date

5 August 2005

1 reference

10 August 2017

1 reference

10 August 2017

92

1 reference

10 August 2017

3

1 reference

10 August 2017

357-360

1 reference

The natural history of left ventricular systolic function in Anderson-Fabry disease.

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Enhanced endothelium-dependent vasodilation in Fabry disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

An Atypical Variant of Fabry's Disease with Manifestations Confined to the Myocardium

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Fabry disease: overall effects of agalsidase alfa treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Monitoring the clinical and biochemical response to enzyme replacement therapy in three children with Fabry disease

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Left ventricular hypertrophy and hypertension

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860797

Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16085718

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16085718

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Generation of myocardial factor images directly from the dynamic oxygen-15-water scan without use of an oxygen-15-carbon monoxide blood-pool scan

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16085718

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/HRT.2004.054015

1 reference

10 August 2017

1 reference

10 August 2017

1 reference